Evaluation of the Effectiveness of Patient Therapeutic Education on Chronic Insomnia
NCT ID: NCT05000528
Last Updated: 2024-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
44 participants
INTERVENTIONAL
2022-09-30
2025-09-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study investigators hypothesize that therapeutic education is more effective as a treatment for chronic insomnia than traditional management in individualized consultation (IC). Thus, therapeutic education could constitute an effective alternative to CBT.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Therapeutic education
therapeutic education
In groups of 5-6, patients will have a one-day therapeutic training session comprising 4 workshops: how to create a sleep agenda; normal sleep; sleep hygiene; medical treatments.
Actimetry
once from inclusion for 2 weeks, second for 2 weeks starting 2 weeks after intervention
Individualized consultation
Actimetry
once from inclusion for 2 weeks, second for 2 weeks starting 2 weeks after intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
therapeutic education
In groups of 5-6, patients will have a one-day therapeutic training session comprising 4 workshops: how to create a sleep agenda; normal sleep; sleep hygiene; medical treatments.
Actimetry
once from inclusion for 2 weeks, second for 2 weeks starting 2 weeks after intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient must be a member or beneficiary of a health insurance plan
* Patient must understand and read French
* Patient with ICSD-3 diagnostic criteria for chronic insomnia: ISI score \> 14/28.
Exclusion Criteria
* Patient with shift work
* Patients scoring \> 10/24 on the Epworth sleepiness scale
* Patient suffering from medical or psychiatric illnesses which may, in the opinion of the investigator, compromise the subject's state of health or ability to participate in the study.
* Patient with chronic alcohol consumption or drug abuse
* Patient unable to express consent.
* Pregnant, parturient or breastfeeding patient.
* The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
* It is impossible to give the subject informed information
* The patient is under safeguard of justice or state guardianship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beatriz Abril
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Nīmes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de NIMES
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Anissa MEGZARI
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIMAO/2020-2/BA-1
Identifier Type: -
Identifier Source: org_study_id